-+ 0.00%
-+ 0.00%
-+ 0.00%
Puma Biotech posts Q2 2026 financial results presentation webcast report
Share
Listen to the news
Puma Biotech posts Q2 2026 financial results presentation webcast report
  • Puma Biotechnology webcast on Q2 2026 financial results showed NERLYNX net revenue of USD 53.6 million.
  • Net revenue rose about 9% from Q2 2025, up about 28% from Q1 2026.
  • Inventory change was -USD 1 million in Q2 2026 versus -USD 1.3 million in Q2 2025.
  • Ex-factory bottles sold totaled 2,929, up about 12% from Q2 2025, up about 26% from Q1 2026.
  • U.S. commercial demand reached 2,986 bottles, up about 11% from Q2 2025, up about 8% from Q1 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Puma Biotechnology Inc. published the original content used to generate this news brief on August 06, 2026, and is solely responsible for the information contained therein.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending